Bausch Health Companies (BHC) EBIT Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 21.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.56% |
| Mar 31, 2026 | -95.12% |
| Dec 31, 2025 | 58.85% |
| Sep 30, 2025 | 36.39% |
| Jun 30, 2025 | 40.23% |
| Mar 31, 2025 | -1.06% |
| Dec 31, 2024 | 14.99% |
| Sep 30, 2024 | -17.87% |
| Jun 30, 2024 | 50.97% |
| Mar 31, 2024 | 48.45% |
| Dec 31, 2023 | 320.59% |
| Sep 30, 2023 | -68.78% |
| Jun 30, 2023 | 158.43% |
| Mar 31, 2023 | -10.97% |
| Dec 31, 2022 | 39.69% |
| Sep 30, 2022 | -9.48% |
| Jun 30, 2022 | -14.43% |
| Mar 31, 2022 | -0.23% |
| Dec 31, 2021 | 144.85% |
| Sep 30, 2021 | 69.92% |